On December 19, 2019 Yield Growth (BOSS.C) announced that it will host an investor conference call and webcast, on January 7th, 2020 at 1 p.m. Vancouver time (4 p.m. in Toronto)  featuring a live presentation by Yield Growth CEO and Co-Founder, Penny White.

Some CEOs struggle to articulate their company’s vision.

Other CEOs can transform a technical manual into a Haiku poem.

Ms. White belongs to the latter category.

Early this year, she spoke to Equity Guru’s Chris Parry about deal making and profit margins in the manufacturing of cannabis health products.

Say what you will, The BOSS team have not been idle in 2019:

BOSS hits 400 Oregon stores
BOSS passes Health Canada testing
BOSS launches 3 hemp-based skin products
BOSS CEO Penny Green explains biz model to Chris Parry
BOSS blends CBD and THC
BOSS tackles the hangover
BOSS launches 10 skin care products
BOSS develops hemp root oil products
BOSS launches scented oils
BOSS expands further into China
BOSS hemp story gets bigger
BOSS featured in Vogue Magazine
BOSS expands CBD formulas in Europe
BOSS doubles down on Shrooms
BOSS now has numbers
BOSS acquires hemp producer

BOSS’s natural hemp skincare brand, Urban Juve, has signed agreements for distribution in Canada, Colombia, Brazil, Costa Rica, Panama, Argentina, El Salvador, Ecuador, Peru, Greece, Cyprus, Bulgaria, Romania and Serbia.

Yield Growth’s Wright & Well brands are launching a THC/CBD line of topical and edible products in Oregon this month and a CBD from hemp topicals line in California in 2020.

Through its subsidiaries, Yield Growth has over 200 proprietary beauty, wellness, edibles and beverage formulas for commercialization. It has filed 13 patents to protect its extraction method and IP. Yield Growth earns revenue through multiple streams including licensing, services and product sales.

The January 7, 2020 presentation will provide shareholders and potential investors with an overview of BOSS’s 2020 expansion strategy, with a focus on the opportunities in functional mushrooms and psychedelic research.

“Yield Growth’s subsidiary, Flourish Mushroom Labs, has filed a U.S. patent application in the U.s. for methods of using serotonin antagonists, and in particular, psychedelic mushroom actives, for weight loss,” writes Joseph Morton on Shroomstocks.ca.“

Psilocin is a cousin of psilocybin, the psychoactive constituent ingredient that puts the magic in magic mushrooms. Yield’s patent contends that both of these chemicals combine to reduce cravings for food, and therefore promote weight loss.

Although ‘magic mushrooms’ remain illegal in most jurisdictions, softening regulations could allow therapeutic mushroom-based compounds to help people in need of alternatives to today’s prescription drugs.

The global market for conventional antidepressants is projected grow to $15.9 billion by 2023.

A study conducted by the Beckley/Imperial Research Programme has provided clinical evidence that psilocybin-assisted psychotherapy can be an effective treatment for depression, even in cases where all other treatments have failed.

Flourish Mushroom Labs pending patent covers the administration of psilocin/psilocybin through microdosing.

“Microdosing, which usually means taking tiny amounts of psychedelics has spread from San Francisco to New York,” explains The Cut, “People say they are using it not to escape their everyday lives but to enhance them. The amounts are sub-perceptual, without the seeing-stuff side effects. They’re still themselves, users say, only a little better.”

Quite frankly, with magic mushroom, microdosing seems like a good first strategy.

When I was 16-years-old, I harvested a large bag of psilocybin mushrooms from the UBC golf course, then ate a handful and wandered east toward the PNE as dawn broke.

At some point on my epic hike, I lost all my history.

I did not know my name, my gender, the city I lived in, the profession of my father, whether I had siblings. It was all gone.

I could not think of one solitary fact that applied only to me. I wandered around for many hours in an alien neighbourhood, terrified, until my history floated back – chopped up into fragments – which I slowly pieced together.

This “bad trip” gave me a lasting insight: knowing who you are is a source of strength, power and direction.

However, I would not wish that experience on my worst enemy.

“My very first time with shrooms (very small dose) was mid-late Dec. At the time, I was about 230-235 (I’m 35 yrs old and 6’2 with dense bones) and was generally out of shape due to lack of exercise,” writes one microdoser on a shroom forum, “I figure I must have lost about 20 pounds of fat, since the increased muscle tone is going to weigh more. Maybe this is just due to the shrooms snapping me out of a depression I didn’t really realize I was in.  Either way, I’m loving it!”

Launching new products in a frontier industry isn’t easy.

“American families, on average, repeatedly buy the same 150 items,” stated the Harvard Business Review, “Even Proctor & Gamble (PG.NYSE) routinely whiffs with product rollouts.”

BOSS’s financial and operational results for Q3, 2019, suggests that the company is getting more hits than whiffs.

Q3, 2019 Financial Highlights:

  • Revenue increased by 61% to $1.9 million
  • Compared to $1.2 million in Q2 2019
  • Revenue increased by 355% compared to $400,000 a year earlier Net losses decreased by 55% to $1.9 million
  • Compared to $4.1 million in Q2 2019
  • Net losses decreased by 50% compared from a year earlier

An April 2019 report by Mordor Intelligence states that the global functional food market is forecasted to grow 8% a year for the next 5 years, reaching USD $34.3 billion by 2024.

Functional foods have a positive effect on health beyond basic nutrition. Example: oatmeal because it “contains soluble fiber that can help lower cholesterol levels.”

You can register for the free Jan 7, 2020 webcast here.

Two days later, on Jan 9, 2020 Equity Guru will be conducting a podcast with Ms. White.

– Lukas Kane

Full Disclosure: Yield Growth is an Equity Guru marketing client.

Written By:

Lukas Kane

Lukas Kane was previously the CEO of a North American investment news syndicate. He was also the Communication Director for a consortium of publicly traded companies. A Senior Writer at Equity.Guru, Mr. Kane writes about mining, cannabis, energy, technology and biotech.

More By This Author
Featured Content
Health Science
5 best Canadian Cannabis companies
bad trip
CBD skin cream
china health and wellness
flourish mushroom labs
functional food
good trip
health and wellness
Mushroom boom
Penny Green
Penny White
psychedelic mushroom
Yield Growth
Yield Growth Corp
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments